Semaglutide is a synthetic 31-amino-acid analogue of human GLP-1 (glucagon-like peptide-1), developed by Novo Nordisk and first authorized by Health Canada in 2018 under the brand name Ozempic
Whether youre experiencing GI symptoms from these medications or dealing with other digestive concerns, the physicians at Cary Gastroenterology specialize in diagnosing and treating a wide range of digestive conditions
Aesthetics 360: Your Partner in Achieving Your Weight Loss Goals As your partner on this journey, Aesthetics 360 is dedicated to providing personalized, comprehensive, and effective solutions that elevate your well-being
Phentermine on the other hand has mild stimulant side effects
Genetic, environmental, and behavioral interactions have been linked to obesity
Top groups like the American Diabetes Association (ADA) and the American Association of Clinical Endocrinology (AACE) recommend these drugs as the first choice for people with type 2 diabetes and heart or kidney disease